Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer’s
Presenters, including Nobel Laureate in Medicine, to discuss innovative treatments for neurodegeneration
Company to feature lead therapeutic’s statistically significant benefits, p < 0.007, for severe Alzheimer’s disease (AD) patients
Related news for (SNPX)
- TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol “TAOX” Effective at Market Open Today
- MoBot’s Stock Market Highlights – 06/30/25 07:00 PM
- 24/7 Market News Snapshot 26 June, 2025 – Synaptogenix, Inc. Common Stock (NASDAQ:SNPX)
- Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol “TAOX” for Alignment with AI-Focused Crypto Treasury Strategy
- Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking